Companies: 10,795·Total market cap: $144.5T
Akanda Corp.

Akanda Corp.

AKANNASDAQHealthcare● Active
$14.65
$-0.98(-6.27%)
Market Cap$474162
P/E Ratio
52W High$209.23424
52W Low$2.2973

Akanda Corp. (AKAN) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · AKAN · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.84M$2.16M$2.62M$0.04M$0.00M
Cost of Revenue$0.63M$2.05M$0.65M$0.76M$0.00M
Gross Profit$0.21M$0.11M$3.27M($0.71M)$0.00M
Gross Margin %(computed)24.91%5.16%124.81%12.27%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
G&A Expenses$4.45M$5.88M$19.85M$5.81M$1.36M
Total Operating Expenses$4.59M$10.16M$22.15M$6.12M$1.67M
Operating Income($4.38M)($10.05M)($20.18M)($2.57M)($1.67M)
Operating Margin %(computed)-523.80%-465.33%-770.18%
Interest Income$0.01M$0.00M$0.00M$0.00M$0.01M
Interest Expense$0.10M$0.26M$0.12M$0.01M$0.65M
Income Before Tax($3.27M)($32.28M)($8.24M)($2.47M)($2.30M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($4.10M)($32.28M)($11.66M)($8.13M)($2.30M)
Net Margin %(computed)-489.57%-445.00%
Per Share & EBITDA
EPS (Basic)$-257.60$-2865532.00$-16828.00$-14066.48$-3980.00
Wtd Avg Shares0.02M0.00M0.00M0.00M0.00M
EBITDA($3.03M)($27.74M)($4.52M)($2.15M)($1.41M)
EBITDA Margin %(computed)-361.82%-172.61%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M

Explore more Akanda Corp. data

About Akanda Corp. (AKAN) Income Statement

Akanda Corp. (AKAN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, AKAN reported revenue of $0.00B, gross profit of $0.00B (gross margin 24.91%), and net income of ($0.00B) — a net profit margin of -489.57%.

Frequently asked questions

AKAN · 4 questions

Akanda Corp. (AKAN) reported revenue of $0.00B for 2024, down 61.3% year-over-year.

AKAN revenueAKAN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09